We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Zumiez Shutters Stores & Withdraws Outlook Due to Coronavirus
Read MoreHide Full Article
The pandemic coronavirus has rattled most companies across the United States, Zumiez Inc. (ZUMZ - Free Report) being no exception. Resultantly, management has issued business updates, including temporary store closures and withdrawal of guidance. Also, retailers such as Abercrombie & Fitch (ANF - Free Report) , Nordstrom (JWN - Free Report) and American Eagle Outfitters (AEO - Free Report) withdrew their initial guidance and closed stores.
As a safety and precautionary measure, the apparel retailer said that it will temporarily shut down all stores across the United States and Canada, effective today till Apr 3. However, it also informed that the duration of closure can be altered as per directions from the government and health officials. Moreover, its Blue Tomato stores in Europe are temporarily shuttered. As of Feb 29, 2020, Zumiez operated 718 stores, including 607 in the United States, 52 in Canada, 48 in Europe and 11 in Australia.
Owing to the outbreak and its impact on revenues and costs, management has withdrawn its first-quarter and fiscal 2020 guidance, issued alongwith its fourth-quarter earnings results on Mar 12. For the fiscal first quarter, Zumiez projected net sales of $219-$223 million and comparable sales (comps) growth of 2-4%. It anticipated consolidated operating margins of 0.4-1.3% and earnings per share of 1-7 cents. For the full fiscal, management estimated comps growth in the low single-digit range and earnings per share of $2.70-$2.80.
During this time off, customers can avail the company’s merchandise via Zumiez.com, Zumiez.ca and blue-tomato.com. This is likely to provide some cushion to the company’s overall top line that is likely to be impacted by loss of sales owing to store closures. We note that the company is striving to expand its e-commerce and omni-channel platforms to provide consumers with quick and easy access to its products. In this regard, Zumiez has considerably improved customer experience by integrating its physical and digital networks. This allows customers to access inventories through all channels alongside availing facilities like buy online, pick up in store, reserve online and pay in store.
We note that shares of the company have tumbled 46.6% in the past three months compared with the industry’s decline of 49.2%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Zumiez Shutters Stores & Withdraws Outlook Due to Coronavirus
The pandemic coronavirus has rattled most companies across the United States, Zumiez Inc. (ZUMZ - Free Report) being no exception. Resultantly, management has issued business updates, including temporary store closures and withdrawal of guidance. Also, retailers such as Abercrombie & Fitch (ANF - Free Report) , Nordstrom (JWN - Free Report) and American Eagle Outfitters (AEO - Free Report) withdrew their initial guidance and closed stores.
As a safety and precautionary measure, the apparel retailer said that it will temporarily shut down all stores across the United States and Canada, effective today till Apr 3. However, it also informed that the duration of closure can be altered as per directions from the government and health officials. Moreover, its Blue Tomato stores in Europe are temporarily shuttered. As of Feb 29, 2020, Zumiez operated 718 stores, including 607 in the United States, 52 in Canada, 48 in Europe and 11 in Australia.
Owing to the outbreak and its impact on revenues and costs, management has withdrawn its first-quarter and fiscal 2020 guidance, issued alongwith its fourth-quarter earnings results on Mar 12. For the fiscal first quarter, Zumiez projected net sales of $219-$223 million and comparable sales (comps) growth of 2-4%. It anticipated consolidated operating margins of 0.4-1.3% and earnings per share of 1-7 cents. For the full fiscal, management estimated comps growth in the low single-digit range and earnings per share of $2.70-$2.80.
During this time off, customers can avail the company’s merchandise via Zumiez.com, Zumiez.ca and blue-tomato.com. This is likely to provide some cushion to the company’s overall top line that is likely to be impacted by loss of sales owing to store closures. We note that the company is striving to expand its e-commerce and omni-channel platforms to provide consumers with quick and easy access to its products. In this regard, Zumiez has considerably improved customer experience by integrating its physical and digital networks. This allows customers to access inventories through all channels alongside availing facilities like buy online, pick up in store, reserve online and pay in store.
Impressively, Zumiez boasts an impressive comps run. The Zacks Rank #3 (Hold) company has seen the 14th successive quarter of positive comps in fourth-quarter fiscal 2019. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Price Performance
We note that shares of the company have tumbled 46.6% in the past three months compared with the industry’s decline of 49.2%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>